ライフサイエンスコーパス: menstrual cycle

1 between diets (and low hormone phase of the menstrual cycle).

2 bility (probability of conception in a given menstrual cycle).

3 erwent imaging weekly, four times during one menstrual cycle.

4 enital than plasma concentrations across the menstrual cycle.

5 to oocytes or matured follicles in a single menstrual cycle.

6 e expressed in all tissues during the entire menstrual cycle.

7 rease during the high-fertility phase of the menstrual cycle.

8 trols, matched with respect to age, sex, and menstrual cycle.

9 yclicity of cortical excitability across the menstrual cycle.

10 n the kinetic parameters and the week of the menstrual cycle.

11 follicular and (2) mid luteal phases of the menstrual cycle.

12 trually in women along with the variation in menstrual cycle.

13 s shed and regenerated each month during the menstrual cycle.

14 ibution for the chance of conceiving in each menstrual cycle.

15 in the high, but not low E(2), phase of the menstrual cycle.

16 women in the low or high E(2) phases of the menstrual cycle.

17 be encountered in vivo throughout the female menstrual cycle.

18 ing mammography during the 1st week of their menstrual cycle.

19 predominantly in premenopausal women at mid menstrual cycle.

20 formance did not differ according to week of menstrual cycle.

21 impaired in women and can be affected by the menstrual cycle.

22 ferent between sexes but not affected by the menstrual cycle.

23 ive hormones important for regulation of the menstrual cycle.

24 attern, in which seizures fluctuate with the menstrual cycle.

25 ular (EFP) and mid-luteal phase (MLP) of the menstrual cycle.

26 t and HIV risk in sex workers with a natural menstrual cycle.

27 obulin A (IgA) and G (IgG) levels during the menstrual cycle.

28 ogen-dominated follicular phase of the human menstrual cycle.

29 cular (EF) and mid-luteal (ML) phases of the menstrual cycle.

30 tween men and women nonsmokers or across the menstrual cycle.

31 and mid-luteal (days 19-25) phases of their menstrual cycle.

32 -measures, counterbalanced design across the menstrual cycle.

33 ith urine PdG during the luteal phase of the menstrual cycle.

34 and stroma during the secretory stage of the menstrual cycle.

35 hnicity, and timing of blood draw within the menstrual cycle.

36 to emotional stimuli is modulated across the menstrual cycle.

37 ed NK cell numbers in endometrium during the menstrual cycle.

38 ations were measured once in days 2-7 of the menstrual cycle.

39 nd couples' knowledge of fertile days of the menstrual cycle.

40 ges of vaginal virus loads (VVLs) during the menstrual cycle.

41 endometrial methylome changes throughout the menstrual cycle.

42 ercising in dry and humid heat, across their menstrual cycle.

43 from women with endometriosis throughout the menstrual cycle.

44 tissue going through remarkable changes each menstrual cycle.

45 pre-receptive and receptive phase within one menstrual cycle.

46 ing the follicular and luteal phases of each menstrual cycle.

47 from three specimens spaced throughout each menstrual cycle.

48 ding and 13 bleeding events unrelated to the menstrual cycle.

49 he progesterone-dominant luteal phase of the menstrual cycle.

50 tic symptoms in the late luteal phase of the menstrual cycle.

51 tenuated by hormonal fluctuations within the menstrual cycle.

52 cular (EF) and mid-luteal (ML) phases of the menstrual cycle.

53 ions in orthostatic tolerance throughout the menstrual cycle.

54 western New York State, were followed for 2 menstrual cycles.

55 ar, ovulatory and mid-luteal phases of their menstrual cycles.

56 s simplex virus type 2 coinfection, during 2 menstrual cycles.

57 from the western New York region for up to 2 menstrual cycles.

58 ound in a cohort of 422 controls with normal menstrual cycles.

59 y women aged 18-44 y were followed for </= 2 menstrual cycles.

60 lowed 259 healthy women for up to 2 complete menstrual cycles.

61 ere between 18 and 40 years old with regular menstrual cycles.

62 est and reference tampons in two consecutive menstrual cycles.

63 normal menstrual cycles through two stressed menstrual cycles.

64 ferences in estrogen exposures or numbers of menstrual cycles.

65 for 6 months or more were followed for three menstrual cycles.

66 matase inhibitors on the dynamics of women's menstrual cycles.

67 A total of 221 participants contributed 706 menstrual cycles.

68 olled, cross-over trials, each lasting three menstrual cycles.

69 ued until the first few days of menses for 6 menstrual cycles.

70 reased by about 2.5% for every additional 10 menstrual-cycles.

71 2 expression, which persisted independent of menstrual cycling.

72 Over one menstrual cycle, 20 human immunodeficiency virus (HIV)-i

73 from Western New York were followed for </=2 menstrual cycles (2005-2007) and provided fasting blood

74 t in a woman densely sampled over a complete menstrual cycle (30 consecutive days).

75 Menstrual cycle activity is the most important risk fact

76 mammography performance according to week of menstrual cycle, adjusting for age and registry.

77 We conclude that the menstrual cycle affects sympathetic neural responses but

78 d during the early follicular phase of their menstrual cycles after ovulatory cycles.

79 (mean age 30+/-4 years, P=0.25) with regular menstrual cycles after validation of the technique.

80 erm contraceptive in the luteal phase of the menstrual cycle also had a 3.25 times higher frequency o

81 hypothesis that hormonal fluctuations of the menstrual cycle alter sympathetic neural activity and or

82 Menstrual cycle alterations and clinically significant o

83 s during hormone titer-defined phases of the menstrual cycle among 37 sex workers from Nairobi, Kenya

84 of 8 women studied during two phases of the menstrual cycle and 3 women studied during their midfoll

85 Hormonal changes across the menstrual cycle and during the postpartum and perimenopa

86 tion between hormone fluctuations during the menstrual cycle and human immunodeficiency virus type 1

87 y symptoms with hormonal changes through the menstrual cycle and imply a potential for individualized

88 to those observed in the luteal phase of the menstrual cycle and modestly increased in the third trim

89 Phase of the current menstrual cycle and OC use were significant determinants

90 a diversity and inflammation (controlled for menstrual cycle and other confounders).

91 ion of hormonal signalling as a phenocopy of menstrual cycle and pregnancy-like endocrine loops and h

92 female volunteers at different stages of the menstrual cycle and pregnant women were assayed.

93 daily early morning urine samples for their menstrual cycle and up to 28 days post day of missed per

94 ory symptoms varied significantly during the menstrual cycle and were most frequent from the midlutea

95 Irregular menstrual cycles and earlier age at menarche increased t

96 cept study that leptin can restore ovulatory menstrual cycles and improve reproductive, thyroid, and

97 st-morning urine specimens during one to two menstrual cycles and male partners collected specimens d

98 equired a familiarisation phase over several menstrual cycles and peer support improved uptake (two s

99 gh it is well established that the number of menstrual cycles and pregnancy (in this case transiently

100 articipants (n = 259) were followed for </=2 menstrual cycles and provided fasting blood specimens </

101 of breast-feeding, use of OCs, and irregular menstrual cycles and the multivariate-adjusted risk of R

102 the markers are measures based on successive menstrual cycles and the subsequent event is the final m

103 of the estrus cycle (equivalent to the human menstrual cycle) and of circulating levels of estradiol

104 recent partners, prior miscarriage, smoking, menstrual cycle, and douching were positively associated

105 nguished by age at onset, variability of the menstrual cycle, and duration of the early transition.

106 s to explain the LH surge in both the normal menstrual cycle, and in the treatment of Kallmann's synd

107 were detected during the luteal phase of the menstrual cycle, and longitudinal analysis showed the fr

108 uish the follicular and luteal phases of the menstrual cycle, and phases were confirmed by hormone me

109 After adjustment for age, phase of menstrual cycle, and presence of known cervical pathogen

110 because these hormones fluctuate across the menstrual cycle, and these fluctuations can complicate c

111 in cervical secretions is influenced by the menstrual cycle, and they suggest that the risk of heter

112 n the periovulatory and luteal phases of the menstrual cycle, and to assess the role of androgens.

113 atients up to 53 y old, predominantly at mid menstrual cycle, and were best coregistered to the fallo

114 ics and hormonal changes associated with the menstrual cycle are possible explanations for variable i

115 performance in such environments across the menstrual cycle are sparse, with mixed findings.

116 cesses, such as cell cycle, circadian clock, menstrual cycles, are governed by oscillatory systems co

117 No or irregular maternal menstrual cycles before pregnancy were associated with h

118 s (mean age 24.3 +/- 4.9 years) with regular menstrual cycles between 23 and 35 days.

119 lls from women in the ovulatory phase of the menstrual cycle but not from men and identify a function

120 vel was associated with a lengthening of the menstrual cycle by 0.93 days (95% confidence interval (C

121 e HPV prevalence preceded the beginning of a menstrual cycle by 9-12 days.

122 om the follicular to the luteal phase of the menstrual cycle by blocking the conversion of progestero

123 Menopause is the time of life when menstrual cycles cease, and is caused by reduced secreti

124 DTI parameters are not sensitive to menstrual cycle changes, while menopause, long-term HRT,

125 w additional questions, information on usual menstrual cycle characteristics can be collected and use

126 amined the associations of risk factors with menstrual cycle characteristics for 309 working women ag

127 immutable host factors, are associated with menstrual cycle characteristics that may in turn be rela

128 (P=0.0078) lower in the luteal phase of the menstrual cycle compared to the follicular phase.

129 ed to target and moderate the effects of the menstrual cycle compared with the effect of simple energ

130 men included in this review are pain and the menstrual cycle, contraception, and preconception counse

131 ype evident in vivo during the course of the menstrual cycle corresponding to fluctuating estradiol l

132 es rarely account for the repeated nature of menstrual cycle data.

133 We assessed endometrial thickness for each menstrual cycle day (as an index of hormone regulation)

134 The menstrual cycle-dependent expression of melanoma antigen

135 The menstrual cycle did not alter resting MSNA (EF, 13 +/- 3

136 dings of the present study indicate that the menstrual cycle does not affect muscle sympathetic nerve

137 These results suggest that the menstrual cycle does not affect sympathetic neural activ

138 s to a greater extent than OCP usage and the menstrual cycle does.

139 based therapies and should be tracked in the menstrual cycle during the course of PTSD treatment.

140 r (PMDD) when given daily or for half of the menstrual cycle during the luteal phase.

141 en concentrations fluctuate over the estrous/menstrual cycle, dynamically modulating estrogen recepto

142 ption, reproductive hormones, and markers of menstrual cycle dysfunction including sporadic anovulati

143 studied: women at 2 different phases of the menstrual cycle (early follicular [early cycle] and late

144 were randomized to receive, for the next two menstrual cycles, either double-blind placebo or dutaste

145 resses genital virus shedding throughout the menstrual cycle, even in the presence of factors reporte

146 s in the follicular and luteal phases of the menstrual cycle (FDR-adjusted p-value <0.05).

147 trial days, separated by >=7 d (males) or 1 menstrual cycle (females), subjects were infused for 120

148 l trigger of fluctuating sex hormones of the menstrual cycle, few studies have been done to confirm o

149 -nAChR availability were observed across the menstrual cycle for any outcome measure.

150 rovided prospectively recorded data on their menstrual cycles for many years.

151 d with placebo plus folic acid for up to six menstrual cycles; for women who conceived, study treatme

152 iated with reduced testosterone and improved menstrual cycle function in healthy premenopausal women.

153 e associations between caffeine exposure and menstrual cycle function, and we are aware of no previou

154 appear to have adverse short-term effects on menstrual cycle function, including sporadic anovulation

155 ssess RR of cycle-average alcohol intake and menstrual cycle function.

156 own between cycle-average alcohol intake and menstrual cycle function.

157 Changes in menstrual cycle functioning associated with PCBs and DDE

158 en during increasing BP (i.e. phase IV); the menstrual cycle had no influences on cardiovagal baroref

159 human papillomavirus (HPV) DNA detection and menstrual cycle has been inconsistent.

160 DSM-IV and timing of their expression in the menstrual cycle have had little empirical support.

161 varian follicles to produce the human 28-day menstrual cycle hormone profile, which controls human fe

162 e scanned twice based on normal variation in menstrual cycle hormones [i.e., early follicular (EF) co

163 ariations in respiratory symptoms during the menstrual cycle in a general population, and potential m

164 s, we hypothesized that BRCA1 influences the menstrual cycle in a way that mimics the factors underly

165 in the follicular phase (day 3) of the last menstrual cycle in all women.

166 nd lesions vary according to the week of the menstrual cycle in benign but not in malignant lesions.

167 HSV entry receptor expression throughout the menstrual cycle in genital tissues was performed, and th

168 n GABA concentrations, fluctuates across the menstrual cycle in healthy women and those with premenst

169 Cortical GABA levels declined across the menstrual cycle in healthy women, whereas women with PMD

170 als, SHIV infections occurred earlier in the menstrual cycle in STI-positive macaques (P = .01, by th

171 progesterone titres during these days of the menstrual cycle in the same groups.

172 tivity did not vary significantly by week in menstrual cycle in women who had undergone mammography m

173 underlying blood pressure control across the menstrual cycle in women with POTS are unknown.

174 mptoms of orthostatic intolerance across the menstrual cycle in women with POTS.

175 mptoms of orthostatic intolerance across the menstrual cycle in women with POTS.

176 different during the EF and ML phases of the menstrual cycle in young, healthy females.

177 (EBT) (n = 13) had a lower body mass, fewer menstrual cycles in the past year, lower estradiol and 2

178 Hormonal fluctuations during the menstrual cycle influence energy intake and expenditure

179 Regulation of the human menstrual cycle is a frequency dependent process control

180 The menstrual cycle is characterized by predictable patterns

181 elia during a mouse estrous cycle or a human menstrual cycle is presently unknown.

182 Regeneration of the endometrium in each menstrual cycle is required for reproduction.

183 The regularity of menstrual cycles is one of the important indicators of f

184 Food intake fluctuates throughout the menstrual cycle; it is greater during the early follicul

185 5% confidence interval (CI): 0.87, 0.97) and menstrual cycle length (for >/=30 days vs. <30 days, OR

186 They also reported their usual menstrual cycle length when not using oral contraceptive

187 [4.00] years and 13 women with no change in menstrual cycle length with a mean [SD] age of 44.92 [2.

188 41] years; including 14 women with change in menstrual cycle length with a mean [SD] age of 45.50 [4.

189 for perimenopause, which is mainly based on menstrual cycle length, was not associated with MAO-A VT

190 here are many studies based on self-reported menstrual cycle length, yet little is known about the va

191 interview with: (1) 7-day or more change in menstrual cycle length; (2) a change in menstrual flow a

192 18-44 years (mean, 27.4) with self-reported menstrual cycle lengths of 21-35 days were recruited in

193 ncy virus (SHIV) susceptibilities during the menstrual cycle, likely caused by cyclic variations in i

194 tion as against single ovulation in a normal menstrual cycle makes the procedure dependent on several

195 We used menstrual cycle markers to determine inception of perime

196 ravings and metabolic changes throughout the menstrual cycle may increase weight loss above that achi

197 onadal hormones, especially estrogen, in the menstrual cycle may play a critical role in fear extinct

198 teroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms.

199 Because intercourse patterns in the menstrual cycles may vary substantially among groups, it

200 hat was tailored to metabolic changes of the menstrual cycle (Menstralean) or to undergo simple energ

201 men were scanned at 2 discrete phases of the menstrual cycle (midcycle and late luteal).

202 to achieve contraception within our previous menstrual cycle models.

203 oids involved in the regulation of the human menstrual cycle modulate gamma-aminobutyric acid (GABA)

204 fluctuate during puberty, pregnancy, and the menstrual cycle, more information about the hormonal mod

205 tate were followed prospectively for up to 2 menstrual cycles (n = 259) during 2005-2007.

206 York were followed prospectively for up to 2 menstrual cycles (n = 259).

207 omen, one in two of such women believe their menstrual cycle negatively impacts training and performa

208 eveloped to model hormonal regulation of the menstrual cycle of a woman from age 20 to 51.

209 estrus but not in the diestrus stage of the menstrual cycle of females was inhibited by pioglitazone

210 After one menstrual cycle of single-blind placebo, participants we

211 nd postmenstrual age (the age since the last menstrual cycle of the mother) from longitudinal recordi

212 e (RR = 1.93, 95% CI: 0.9, 4.0 for >900 mg), menstrual cycles of use (RR = 2.16, 95% CI: 0.9, 5.2 for

213 ilability of daily hormone values for entire menstrual cycles offers an opportunity to apply new anal

214 remains controversial, and the effect of the menstrual cycle on MSNA responses to mental stress is un

215 The influence of the menstrual cycle on resting muscle sympathetic nerve acti

216 he impact of hormonal fluctuation during the menstrual cycle on the course of bipolar disorder is poo

217 cted urine samples during 1997-1999 from one menstrual cycle or up to 50 days from 848 women who live

218 s was stronger among women with >30 years of menstrual cycles (OR 0.66; 95% CI 0.51-0.85) than those

219 -0.85) than those with a shorter duration of menstrual cycles (OR 0.97; 95% CI 0.73-1.27), and the te

220 e not significantly affected by phase of the menstrual cycle, oral contraceptive use, or early pregna

221 ture chances of pregnancy from the number of menstrual cycles over which they have been trying to con

222 2); this sensitivity was not affected by the menstrual cycle (P = 0.747).

223 Three patients had an ovulatory menstrual cycle (P<0.05 for the comparison with an expec

224 patterns of reproductive hormones across the menstrual cycle, particularly ultradian rhythms, are wel

225 men in the low oestrogen (E(2)) phase of the menstrual cycle, PE evoked a decrease in cRCF (30-40%; P

226 age 18-50 years; 115 male and 45 female) and menstrual cycle phase (29 follicular and 16 luteal) effe

227 on of sleep and waking while controlling for menstrual cycle phase and hormonal contraceptive use.

228 e group, prospective, observational trial of menstrual cycle phase and outcome after breast cancer su

229 ed Cl- secretion in women with CF during the menstrual cycle phase at which 17beta-estradiol level is

230 Cl(-) secretion in women with CF during the menstrual cycle phase at which 17beta-estradiol level is

231 re scanned twice during the early follicular menstrual cycle phase compared with late follicular/midc

232 Menstrual cycle phase does not appear to affect exercise

233 ed for standardization of CRP measurement to menstrual cycle phase in reproductive-aged women.

234 The data also demonstrate that menstrual cycle phase is an important consideration in f

235 study investigated the influence of sex and menstrual cycle phase on the recall of fear extinction.

236 cal confirmation of overnight abstinence and menstrual cycle phase, analyses were performed to compar

237 with genital antiretroviral concentrations, menstrual cycle phase, bacterial vaginosis, genital blee

238 se in well-trained women are not affected by menstrual cycle phase, but differ between dry and humid

239 Our data show menstrual cycle phase-associated changes in both endocer

240 nstrual dysphoric disorder (PMDD) and that a menstrual cycle phase-dependent abnormality in brain GAB

241 response circuitry were dependent on women's menstrual cycle phase.

242 tervention for breast cancer on the basis of menstrual cycle phase.

243 rrelated with estradiol level, regardless of menstrual cycle phase.

244 l linguistic stimuli varies depending on the menstrual cycle phase.

245 follicular (V-FP(imm)) or luteal (V-LP(imm)) menstrual cycle phase.

246 Planning study visits during specific menstrual cycle phases is important if the exposure or o

247 When menstrual cycle phases were strictly defined, neither DF

248 essions occurring during hormonally distinct menstrual cycle phases.

249 t and temporally to the estrous phase of the menstrual cycle, potentially decreasing the risk of mate

250 d as resumed by the occurrence of at least 1 menstrual cycle), pregnancies, and disease-free survival

251 human endometrial transformation across the menstrual cycle, providing insights into this essential

252 ar menstrual cycle, undergoing treatment for menstrual cycle regularity shortly after menarche, havin

253 anscranial magnetic stimulation to determine menstrual cycle-related changes in cortical excitability

254 regnancy, typically defined as the number of menstrual cycles required to achieve a clinical pregnanc

255 metrium at single-cell resolution across the menstrual cycle, resolving cellular heterogeneity in mul

256 Menstrual cycle-specific estimates of urinary BPA and ph

257 In a non-stressed menstrual cycle, SS animals have lower levels of estroge

258 Menstrual cycle status was based on the last menstrual p

259 trated that a small endogenous rhythm of the menstrual cycle still affects T(core) and also that chro

260 ns proposed that an endogenous rhythm of the menstrual cycle still occurs with OCP usage.

261 Hormone parameters, menstrual cycle, symptoms of hypogonadism, and offspring

262 and progesterone levels at times during the menstrual cycle that are critical for ovulation and earl

263 In a human menstrual cycle the endometrium undergoes remodeling, sh

264 ity to HIV during the secretory phase of the menstrual cycle, the molecular mechanisms involved remai

265 the BioCycle Study were followed for up to 2 menstrual cycles; they provided fasting blood specimens

266 ly stress-resilient (HSR) and exhibit normal menstrual cycles through two stressed menstrual cycles.

267 trial cancer, we created the total number of menstrual cycles (TNMC) that a woman experienced during

268 rointestinal system, adjusts itself with the menstrual cycle to control the passage of sperm, and shi

269 1650 women with regular menstrual cycles undergoing their first cycle of in-vitr

270 between thyroid cancer and having irregular menstrual cycle, undergoing treatment for menstrual cycl

271 of demographic characteristics, phase of the menstrual cycle, use of hormonal contraceptives, and con

272 Normal menstrual cycle variations in cortical excitability are

273 The follicular phase of the menstrual cycle was associated with an elevated CCL2 lev

274 he mutations adjusted for age and day of the menstrual cycle was higher (odds ratio [OR] 1.11, 95% CI

275 Regular menstrual cycle was reported by more than 90% of female

276 he endogenous fluctuation in E(2) during the menstrual cycle, we conducted a within-person repeated-m

277 reports and daily symptom ratings during one menstrual cycle were examined in 70 depressed perimenopa

278 Significant rhythmic variations over the menstrual cycle were found in each symptom for all subje

279 in premenopausal women according to week of menstrual cycle were studied by using prospectively coll

280 Genital secretions and tissues during the menstrual cycle were studied.

281 r, periovulatory, and luteal phases of their menstrual cycle were studied.

282 Six healthy women with regular menstrual cycles were administered the NKB antagonist AZ

283 Very irregular menstrual cycles were associated with an increased risk

284 Female individuals with epilepsy and regular menstrual cycles were eligible for this prospective stud

285 Healthy women with normal menstrual cycles were randomly assigned to use either a

286 More than 500 menstrual cycles were studied totaling over 8,000 days.

287 rea and were 20-40 years of age, had regular menstrual cycles, were not taking oral contraceptives, a

288 were stratified according to the week of the menstrual cycle when MR imaging was performed.

289 This could be the case during the menstrual cycle, when using hormone-based birth control,

290 breast DTI is not restricted throughout the menstrual cycle, whereas the modulations in diffusion pa

291 he epithelium of human vagina throughout the menstrual cycle, whereas the mouse vaginal epithelium ex

292 the use of oral contraceptives and return of menstrual cycle, which is subject to further investigati

293 Women with regular menstrual cycles who presented to a participating family

294 eatability, remaining almost equal along the menstrual cycle, with a low mean within-subject coeffici

295 V/SHIV has been recently associated with the menstrual cycle, with particular susceptibility observed

296 s relatively stable during this stage of the menstrual cycle, with small-scale changes affecting 5% o

297 y premenopausal women were followed for </=2 menstrual cycles, with biomarkers of lipid peroxidation

298 and had 1 year of normal weight and regular menstrual cycles, without binge eating or purging.

299 ggest that for about one week of a four-week menstrual cycle, women with CF will have a reduced abili

300 cise performance is not different across the menstrual cycle, yet is lower in humid heat, in conjunct